The Omics-Based Clinical Trials Market in 2023 is US$ 30.35 billion, and is expected to reach US$ 54.6 billion by 2031 at a CAGR of 7.60%. FutureWise Research published a report that analyzes Omics-Based Clinical Trials Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based...